A $70 million grant to researchers at Clemson University is expected to foster economic development and keep the U.S. biopharmaceutical industry at the forefront.
Announced last week, the grant from the Commerce Department brings the Clemson-based National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) on board with 11 other entities in the Manufacturing USA network. This network is a consortium of public-private partnerships “connects people, ideas, and technology to solve industry-relevant advanced manufacturing challenges,” according to the network’s website.
An additional $129 million from 150 companies, educational institutions and other entities will also fund the NIIMBL.
“The institute will help foster economic development, improve medical treatments and ensure a qualified workforce by collaborating with educational institutions to develop new training programs matched to specific biopharma skill needs,” Clemson’s news release said.
In addition to site co-directors Sarah W. Harcum (bioengineering) and Ken R. Marcus (chemistry), other members of the Clemson team include Mark Blenner, chemical and biomolecular engineering; Terry Bruce, Clemson Light Imaging Facility; Richard Groff, electrical and computer engineering; Scott Husson, chemical and biomolecular engineering; JeongSoo Lee, bioengineering; Laine M. Mears, automotive engineering department at the Clemson University International Center for Automotive Research; Christopher Saski, Clemson University Computational Genomics Laboratory; Nishanth Tharayil, agricultural and environmental sciences; and Pingshan Wang, electrical and computer engineering.